Jaguar Gene Therapy
Jaguar Gene Therapy is a startup based in the United States, most recent round Series B, 1 tracked investor.
About Jaguar Gene Therapy
Jaguar Gene Therapy is a startup founded in 2021 based in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Jaguar Gene Therapy is a clinical-stage biotechnology company focused on accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, including those affecting sizable patient populations. The company is advancing a pipeline of gene therapies targeting diseases with significant unmet needs, such as genetic causes of autism spectrum disorder, Phelan-McDermid syndrome, Type 1 galactosemia, and Type 1 diabetes.
Explore Jaguar Gene Therapy's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.